SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-22-296700
Filing Date
2022-12-02
Accepted
2022-12-01 17:33:32
Documents
6
Group Members
ALBERT CHADAN ESTESFHMLS X, L.L.C.FHMLS X, L.P.FHMLS XI, L.L.C.FHMLS XI, L.P.FHMLSP OVERAGE, L.L.C.FHMLSP OVERAGE, L.P.FHMLSP, L.L.C.FHMLSP, L.P.FRAZIER LIFE SCIENCES OVERAGE FUND L.P.FRAZIER LIFE SCIENCES PUBLIC FUND, L.P.FRAZIER LIFE SCIENCES X, L.P.FRA

Document Format Files

Seq Description Document Type Size
1 SC 13D d425988dsc13d.htm SC 13D 327604
2 EX-99.1 d425988dex991.htm EX-99.1 16708
3 EX-99.2 d425988dex992.htm EX-99.2 7314
4 EX-99.3 d425988dex993.htm EX-99.3 7240
5 EX-99.4 d425988dex994.htm EX-99.4 7307
6 EX-99.5 d425988dex995.htm EX-99.5 7249
  Complete submission text file 0001193125-22-296700.txt   375636
Mailing Address TWO UNION SQUARE 601 UNION STREET SUITE 3200 SEATTLE WA 98101
Business Address TWO UNION SQUARE 601 UNION STREET SUITE 3200 SEATTLE WA 98101 617-570-8364
Frazier Lifesciences Sponsor LLC (Filed by) CIK: 0001828906 (see all company filings)

IRS No.: 981562544 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D

Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Subject) CIK: 0001936258 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-93833 | Film No.: 221439751
SIC: 2834 Pharmaceutical Preparations